Mylan will distribute Natco's Generic Copaxone in the US
Submitted by art on Thu, 2008-06-26 06:43.
Natco Pharma announced it has signed a licence and supply agreement with US-based Mylan for the global sale of generic version of Teva's patented 'Copaxone', a drug prescribed for multiple sclerosis.
I wonder how soon insurance companies are going to start substituting the generic?
Post new comment